Table 6.

What is considered to be a mitigation success in shortages among participants.

“What is a success in mitigating shortages?”	Country
“When we don't have to let patients untreated.”	Germany
“No obvious harm to patients.”; “The shortage was managed without patient harm.”; “Preventing harm to patients through overcoming complete medicine shortages and finding alternatives.”	Bosnia and Herzegovina, Ireland, Serbia, UK
“Shortages were not met by healthcare professionals and patients.”	Finland
“The number of reported shortages in Norway is growing rapidly but the extra cost is reduced. The time spent at each hospital handling shortage is not growing proportionally to the increase in reported shortages.”	Norway
“We managed to get necessary medicines.”	Slovenia
“Keeping the medicine for vulnerable population-those who cannot be treated with alternative.”	Israel
	Switzerland
“Efficient prioritization of patients and effective communication with a physician”	France
“Rational use of product severely affected by a shortage or providing a suitable alternative”	Belgium
“Being able to redistribute a medicine, compound or import it.”; “Having tools for: 1. Communicating if a product is in shortage to the prescribers and nurses 2. Drug shortage catalogue and reporting systems (institutional and national) 3. Finding alternative sources (e.g.: importation) 4. Change in formulary”	Hungary